Search

Your search keyword '"Ferrara, James L.M."' showing total 485 results

Search Constraints

Start Over You searched for: Author "Ferrara, James L.M." Remove constraint Author: "Ferrara, James L.M."
485 results on '"Ferrara, James L.M."'

Search Results

1. A Day 14 Endpoint for Acute GVHD Clinical Trials

3. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

4. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

5. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis

6. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

7. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

10. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

12. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease

13. Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

14. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

15. Contributors

17. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD

18. A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality

20. Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy

21. Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis

23. Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

25. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

34. Pathogenic mechanisms of Acute Graft versus Host Disease

35. Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation

36. A biomarker panel for acute graft-versus-host disease

46. Contributors

50. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

Catalog

Books, media, physical & digital resources